Michael Geffner's most recent trade in Immunovant Inc was a trade of 2,595 Common Stock done at an average price of $19.0 . Disclosure was reported to the exchange on Oct. 22, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunovant Inc | Michael Geffner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 19.03 per share. | 22 Oct 2025 | 2,595 | 217,958 (0%) | 0% | 19.0 | 49,383 | Common Stock |
| Immunovant Inc | Michael Geffner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 16.30 per share. | 08 Oct 2025 | 1,272 | 220,553 (0%) | 0% | 16.3 | 20,734 | Common Stock |
| Immunovant Inc | Michael Geffner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 18.15 per share. | 23 Jul 2025 | 2,385 | 221,825 (0%) | 0% | 18.2 | 43,288 | Common Stock |
| Immunovant Inc | Michael Geffner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 17.24 per share. | 09 Jul 2025 | 1,160 | 224,210 (0%) | 0% | 17.2 | 19,998 | Common Stock |
| Immunovant Inc | Michael Geffner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 14.79 per share. | 23 Apr 2025 | 2,349 | 225,370 (0%) | 0% | 14.8 | 34,742 | Common Stock |
| Immunovant Inc | Michael Geffner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 12.99 per share. | 09 Apr 2025 | 6,169 | 227,719 (0%) | 0% | 13.0 | 80,135 | Common Stock |
| Immunovant Inc | Michael Geffner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 143,063 | 143,063 | - | - | Stock Option (right to buy) | |
| Immunovant Inc | Michael Geffner | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Apr 2025 | 101,574 | 233,888 (0%) | 0% | 0 | Common Stock | |
| Immunovant Inc | Michael Geffner | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 23.59 per share. | 22 Jan 2025 | 2,657 | 132,314 (0%) | 0% | 23.6 | 62,679 | Common Stock |
| Immunovant Inc | Michael Geffner | Chief Medical Officer | 23 Oct 2024 | 3,189 | 134,971 (0%) | 0% | 29.5 | 94,171 | Common Stock | |
| Immunovant Inc | Michael Geffner | Chief Medical Officer | 24 Jul 2024 | 3,456 | 138,160 (0%) | 0% | 27.8 | 95,939 | Common Stock | |
| Immunovant Inc | Michael Geffner | Chief Medical Officer | 24 Apr 2024 | 3,261 | 141,616 (0%) | 0% | 28.9 | 94,243 | Common Stock | |
| Immunovant Inc | Michael Geffner | Chief Medical Officer | 02 Apr 2024 | 68,723 | 68,723 | - | - | Stock Option (right to buy) | ||
| Immunovant Inc | Michael Geffner | Chief Medical Officer | 02 Apr 2024 | 54,978 | 144,877 (0%) | 0% | 0 | Common Stock | ||
| Immunovant Inc | Geffner Michael | Chief Medical Officer | 26 Jan 2024 | 9,948 | 90,052 (0%) | 0% | 37.9 | 377,129 | Common Stock | |
| Immunovant Inc | Michael Geffner | Chief Medical Officer | 26 Jan 2024 | 153 | 89,899 (0%) | 0% | 38.5 | 5,883 | Common Stock |